Login / Signup

Quantitative survival impact of composite treatment delays in head and neck cancer.

Allen S HoSungjin KimMourad TighiouartAlain MitaKevin S ScherJoel B EpsteinAnna LauryRavi PrasadNabilah AliChrysanta PatioJon Mallen-St ClairZachary S Zumsteg
Published in: Cancer (2018)
Increasing delays in postoperative and radiation intervals are associated independently with an escalating risk of mortality that plateaus beyond certain thresholds. Delays in initiating therapy, conversely, are eclipsed in importance when appraised in conjunction with the entire treatment course. Such findings may redirect focus to streamlining those intervals that are most sensitive to delays when considering survival burden. Cancer 2018. © 2018 American Cancer Society.
Keyphrases
  • papillary thyroid
  • squamous cell
  • patients undergoing
  • combination therapy
  • risk factors
  • free survival
  • radiation therapy
  • mass spectrometry
  • young adults
  • bone marrow
  • radiation induced